These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15228454)

  • 1. In-situ lobular/myoepithelial neoplasia of the breast.
    Shousha S; Knee G
    Histopathology; 2004 Jul; 45(1):93-5. PubMed ID: 15228454
    [No Abstract]   [Full Text] [Related]  

  • 2. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
    Shousha S
    Histopathology; 2011 Jun; 58(7):1081-5. PubMed ID: 21707709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Reis-Filho JS; Cancela Paredes J; Milanezi F; Schmitt FC
    Cancer; 2002 Apr; 94(7):2114-5; author reply 2115-6. PubMed ID: 11932917
    [No Abstract]   [Full Text] [Related]  

  • 4. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
    Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
    [No Abstract]   [Full Text] [Related]  

  • 5. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
    Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
    Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma.
    Alvarado-Cabrero I; Picón Coronel G; Valencia Cedillo R; Canedo N; Tavassoli FA
    Arch Med Res; 2010 Aug; 41(6):436-41. PubMed ID: 21044747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomorphological features of a metastatic myoepithelial carcinoma arising in a minor salivary gland.
    Gupta K; Dey P; Das A
    Diagn Cytopathol; 2005 Jul; 33(1):56-7. PubMed ID: 15945094
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S; Sim SJ; Lu L
    Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
    Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
    Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure malignant myoepitheliomas of the breast: an immunohistochemical study.
    Kapoor N; Chinoy RF
    Indian J Pathol Microbiol; 2006 Apr; 49(2):279-81. PubMed ID: 16933741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
    Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
    Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
    Fadare O
    Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent data on lobular neoplasia of the breast: the pathologist's opinion].
    Bibeau F; Borrelly C; Chateau MC; Saingra B; Lemanski C; Masson B; Rouanet P; Gutowski M
    Bull Cancer; 2005 May; 92(5):453-8. PubMed ID: 15932809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma.
    Sentani K; Tashiro T; Oue N; Yasui W
    APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414
    [No Abstract]   [Full Text] [Related]  

  • 16. Pure or mixed-type invasive lobular carcinoma?
    Bulut N; Dede DS; Sari E; Altundag K
    Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomyoepithelioma of the breast with undifferentiated carcinoma component.
    Michal M; Baumruk L; Burger J; Manhalová M
    Histopathology; 1994 Mar; 24(3):274-6. PubMed ID: 7515373
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular carcinoma of the breast with hybrid myoepithelial and secretory ("myosecretory") cell differentiation.
    Del Vecchio M; Foschini MP; Peterse JL; Eusebi V
    Am J Surg Pathol; 2005 Nov; 29(11):1530-6. PubMed ID: 16224222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.